Literature DB >> 2172266

High-performance liquid chromatographic determination of the H+/K+ ATPase inhibitor (BY 1023/SK&F 96,022) and its sulphone metabolite in serum or plasma by direct injection and fully automated pre-column sample clean-up.

R Huber1, W Müller, M C Banks, S J Rogers, P C Norwood, E Doyle.   

Abstract

A fully automated high-performance liquid chromatographic method is described for the determination of the new H+/K+ ATPase inhibitor BY 1023/SK&F 96,022 and its major metabolite occurring in dog serum. The method uses direct sample injection of up to 200 microliters and a pre-column switching technique. In order to optimize the recovery, pre-column conditions were varied systematically with respect to the pH of the pre-column eluent, its buffering capacity and content of acetonitrile. Optimization resulted in near 100% recovery for both compounds, thus allowing the use of external standardization. The linearity range, precision and detection limits were determined and the method shown to be applicable to both serum and plasma. The method was applied to define the pharmacokinetics in dogs and humans.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2172266     DOI: 10.1016/s0378-4347(00)83845-1

Source DB:  PubMed          Journal:  J Chromatogr


  5 in total

1.  Effect of CYP2C19*2 and *17 mutations on pharmacodynamics and kinetics of proton pump inhibitors in Caucasians.

Authors:  Nicole G Hunfeld; Ron A Mathot; Daan J Touw; Ron H van Schaik; Paul G Mulder; Paul F Franck; Ernst J Kuipers; William P Geus
Journal:  Br J Clin Pharmacol       Date:  2008-01-30       Impact factor: 4.335

Review 2.  Pantoprazole. A review of its pharmacological properties and therapeutic use in acid-related disorders.

Authors:  A Fitton; L Wiseman
Journal:  Drugs       Date:  1996-03       Impact factor: 9.546

3.  Chiral chromatography and multivariate quantitative structure-property relationships of benzimidazole sulphoxides.

Authors:  P Camilleri; D J Livingstone; J A Murphy; D T Manallack
Journal:  J Comput Aided Mol Des       Date:  1993-02       Impact factor: 3.686

4.  Reversible pheripheral edema in female patients taking proton pump inhibitors for peptic acid diseases.

Authors:  G Brunner; C Athmann; J H Boldt
Journal:  Dig Dis Sci       Date:  2001-05       Impact factor: 3.199

5.  Proton pump activation in stimulated parietal cells is regulated by gastric acid secretory capacity: a human study.

Authors:  David C Metz; Geraldine M Ferron; Jeffrey Paul; Mary Beth Turner; Elaine Soffer; Joseph R Pisegna; Wieslaw J Bochenek
Journal:  J Clin Pharmacol       Date:  2002-05       Impact factor: 3.126

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.